ARWR
#845
Arrowhead Pharmaceuticals, Inc. - Common Stock
81.3 7 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.17%
Variación mensual
-2.70%
Variación en los últimos 6 meses
+32.14%
Cambio anual
+108.11%
Cierres anteriores
84.9 1
Open
81.5 3
Mínimo
81.1 9
Máximo
81.7 2
Volumen
341
Financials
- Market Capitalization 11.49 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-37.39
Relación precio/flujo de caja
16.85
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 815 |  CORT Corcept Therapeutics Incorporated - Common Stock | 112.49 USD | -1.22% | -7.36% | -1.46% | +53.32% | 12.16 B USD | ||
| 817 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 106.09 USD | +0.70% | -1.32% | +28.44% | +58.82% | 12.04 B USD | ||
| 850 |  TECH Bio-Techne Corp - Common Stock | 72.33 USD | -0.03% | -0.01% | +0.26% | +33.52% | 11.34 B USD | ||
| 871 |  SMMT Summit Therapeutics Inc. - Common Stock | 13.64 USD | -0.66% | +8.08% | +5.33% | -31.32% | 10.88 B USD |